Recommended Antibiotic Packet for Urinary Tract Infections
For uncomplicated UTIs in non-pregnant adults, first-line treatments are nitrofurantoin 100 mg twice daily for 5 days, trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 3 days, or fosfomycin 3g single dose. 1
First-Line Treatment Options for Uncomplicated UTIs
Non-pregnant Adults
- Nitrofurantoin 100 mg twice daily for 5 days (high strength of evidence) 1
- TMP-SMX 160/800 mg twice daily for 3 days 1, 2
- Fosfomycin 3g single dose (moderate strength of evidence) 1
- Pivmecillinam 400 mg twice daily for 5 days (moderate strength of evidence) 1
Rationale for First-Line Choices
These recommendations are based on efficacy, resistance patterns, and side effect profiles. Nitrofurantoin and fosfomycin maintain high susceptibility rates against common uropathogens (E. coli sensitivity to fosfomycin: 95.5%, nitrofurantoin: 85.5%) 1, 3.
Second-Line Options
- Amoxicillin-clavulanate 500/125 mg twice daily for 3-7 days 1
- Cephalexin 500 mg four times daily for 5-7 days 1
- Fluoroquinolones (e.g., ciprofloxacin 500-750 mg twice daily for 7 days) 1
CAUTION: Fluoroquinolones should be reserved for more invasive infections due to increasing resistance rates (39.9% for E. coli) and potential for adverse effects 1, 3, 4.
Special Populations
Pregnant Women
- Nitrofurantoin or Cephalexin as first-line treatments 1
- AVOID TMP-SMX in first and third trimesters (risk of neural tube defects and kernicterus) 1
- AVOID tetracyclines throughout pregnancy (contraindicated) 1
Men
- All UTIs in men are considered complicated and require a 14-day course of antibiotics 1
- Consider potential concurrent prostatitis when selecting treatment 1
Patients with Renal Impairment
For levofloxacin dosing based on creatinine clearance 1:
- ≥50 mL/min: 750 mg once daily for 5 days (normal dose)
- 20-49 mL/min: 500 mg once daily
- 10-19 mL/min: 250 mg once daily
- Hemodialysis or Peritoneal Dialysis: 250-500 mg every 48 hours (post-HD on dialysis days)
For TMP-SMX in renal impairment 2:
- CrCl >30 mL/min: Standard regimen
- CrCl 15-30 mL/min: Half the usual regimen
- CrCl <15 mL/min: Not recommended
Antibiotic Resistance Considerations
- E. coli is the most common pathogen (39-81% of cases) 1
- Local resistance patterns should guide empiric therapy 1, 3
- Obtain urine culture before starting antibiotics when possible 1
- For suspected resistant organisms (recent antibiotic exposure, healthcare-associated infection):
Prevention of Recurrent UTIs
For patients with ≥3 UTIs per year or ≥2 in the last 6 months 1:
- Increased fluid intake
- Vaginal estrogens in postmenopausal women
- Consider prophylactic antibiotics:
- Post-coital single dose
- Daily low-dose nitrofurantoin
- Non-antibiotic alternatives: methenamine hippurate, cranberry products, lactobacillus probiotics
Important Caveats
- Do not treat asymptomatic bacteriuria except in pregnant women or before urological procedures 1
- Change indwelling catheters before collecting urine samples for culture 1
- Catheter-associated UTIs may require broader coverage for resistant organisms 1
- Diabetes, chronic kidney disease, immunosuppression, and urinary catheterization are risk factors for recurrent and complicated UTIs 1
Following these evidence-based recommendations will help ensure optimal treatment outcomes while minimizing antibiotic resistance development.